Botulinum Toxin Injections for Spasticity ManagementInfo Course Information![]() Why join this course?Botulinum toxin type A (Botox, Dysport, Xeomin) blocks the release of a neurotransmitter known as acetylcholine from nerve cells. Acetylcholine normally transmits nerve impulses to muscle cells, causing them to contract. Without acetylcholine, the affected nerve is unable to send a signal to the muscle it supplies, resulting in a weakened or paralysed muscle. The effect of Botox injections is restricted to the area being treated. The aim of the injection therapy module is to enable practitioners from relevant health care professions to develop in-depth knowledge and understanding of how the mechanisms of Botulinum Toxin action are related to therapeutic and adverse effects. This will allow for practitioners to advance their practice as independent injectors developing roles such as ACPs and enable autonomous practice. Medical practitioners will develop greater skills around injection therapy including localisation techniques, and case study analysis to enable advanced clinical reasoning skills AudienceThis credit bearing module is particularly suited to: physiotherapists, consultant stroke physicians, Rehabilitation medicine and neurology trainees, and nurses.
Course CodeBotulinum Toxin Injections for Spasticity Manageme Course LeaderClaire Ward/Aimee Pinto/Mike Dunn
|
Contact
General enquiries
St George's, University of London
Cranmer Terrace
London SW17 0RE
020 8672 9944
General enquiries
St George's, University of London
Cranmer Terrace
London SW17 0RE
020 8672 9944

© St George's, University of London